Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-210-2 | CAS number: 178452-71-6 OLIVE-GREEN JB 1170
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- Adopted July 17, 1992 (reported París 29 April 1993).
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- July 31, 1992
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An in vitro or in chemico skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study (different from LLNA test) is available.
Test material
- Reference substance name:
- Pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
- EC Number:
- 419-210-2
- EC Name:
- Pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
- Cas Number:
- 178452-71-6
- Molecular formula:
- C66H48CrN16Na5O28S6
- IUPAC Name:
- chromium(3+) pentasodium bis(7-{4-[2-(1-butyl-5-cyano-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridin-3-yl)diazen-1-yl]benzenesulfonamido}-2-[2-(5-nitro-2-oxido-3-sulfonatophenyl)diazen-1-yl]-3-sulfonatonaphthalen-1-olate)
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Himalayan spotted
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
-Source: BRL, Biological Research Laboratories Ltd. Wölferstrasse 4, 4414 Füllinsdorf/Switzerland
-Females nulliparous and non-pregnant:yes
-Age at study initiation: 5 - 7 weeks
-Weight at study initiation: 402 - 466 g
-Housing: individually in Makrolon type-3 cages with autoclaved standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz).
-Diet: pelleted standard Kliba 342, Batch no. 66/94 (from 28-DEC-1995) and 67/94 (from 28-JAN-1994) guinea pig breeding/maintenance diet ("Kliba", KlingentalmOhle AG, CH-4303 Kaiseraugst), ad libitum.
-Water: community tap water from Füllinsdorf, ad libitum. Once weekly additional supply of ascorbic acid (1 g/l) via the drinking water
-Acclimation period: one week for the control and test groups, whereas no acclimatlzation for the animals of the pretest.
-Indication of any skin lesions: only animals without any visual signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
-Temperature: 20 - 22 °C
-Humidity: 51 - 68 %
-Air changes: 10 - 15 air changes per hour
-Photoperiod: 12 hours cycle dark/light with artificial fluorescent light (approx.100 Lux)
-Other: music during the light period.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
- Concentration / amount:
- 0 %
- Day(s)/duration:
- single injection
- Route:
- intradermal
- Vehicle:
- water
- Concentration / amount:
- 5 %
- Day(s)/duration:
- single injection
- Route:
- intradermal
- Vehicle:
- other: emulsion in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
- Concentration / amount:
- 5 %
- Day(s)/duration:
- single injection
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- other: vaselinum album
- Concentration / amount:
- 25 %
- Day(s)/duration:
- 48 hours
Challenge
- No.:
- #1
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- other: vaselinum album
- Concentration / amount:
- 3 %
- Day(s)/duration:
- 24 hours
- No. of animals per dose:
- -Intracutaneous Pretest: 2
-Epidermal Pretest I: 4
-Epidermal pretest II: 4
-Control Group: 10
-Test Group: 20 - Details on study design:
- PRETEST
The objective of this investigation was to identify a maximally tolerated concentration of the test item suitable for the induction phase of the main study. In addition, a suitable non-irritant concentration of the test item, by the topical route of administration, was identified for the challenge application.
INDUCTION EXPOSURE: INTRADERMAL INJECTION
-No. of exposures: 1
-Test groups: 2 guinea pigs
-Site: clipped flank
-Frequency of applications: single injection
-Concentrations: 0.1 ml/site of 5, 3 and 1% of the test item in bi-distilled water.
-Evaluation: the resulting dermal reactions were assessed 24 hours later.
INDUCTION EXPOSURE: EPIDERMAL APPLICATION
-No. of exposures: 4 applications of filter paper ( 2 x 2 cm) saturated with test item
-Exposure period: 24 hours
-Test groups: 4 guinea pigs
-Site: clipped and shaved flanks
-Protection site: the patches were covered by a strip of aluminium foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. This procedure ensured the intensive contact of the test item.
-Concentrations in vaselium album:
A = 25 %
B = 15 %
C = 10 %
D = 5 %
-Evaluation: the reaction sites were assessed 24 and 47 hours after removal of the bandage for erythema and oedema.
INDUCTION EXPOSURE: EPIDERMAL APPLICATION II (to determined the highest non-irritating concentration)
-No. of exposures: 4 applications of filter paper ( 2 x 2 cm) saturated with test item
-Exposure period: 24 hours
-Test groups: 4 guinea pigs
-Site: shaved flanks
-Protection site: the patches were covered by a strip of aluminium foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. This procedure ensured the intensive contact of the test item.
-Concentrations in vaselinum album:
A = 3 %
B = 1 %
C = 0.5 %
D = 0.3 %
-Evaluation: the test sites were depilated approximately 21 hours after removing of the dressing.
MAIN STUDY
A1. INDUCTION EXPOSURE: INTRADERMAL INJECTIONS (performed on test day 1)
-No. of exposures: three pairs of injections (0.1 ml/site)
-Exposure period: single injection
-Test groups: 20 female guinea pigs
-Control group: 10 female guinea pigs
-Site: scapular region (4 x 6 cm) in the clipped region
-Frequency of applications: one application for each site
-Concentrations:
test group:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) The test item diluted to 5% with bi-distilled water
3) The test item diluted to 5% by emulsion in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
control Group:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) bi-distilled water
3) 1:1 (w/w) mixture of bi-distilled water in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
A2. INDUCTION EXPOSURE: EPIDERMAL APPLICATION (performed on test day 8)
-No. of exposures: one application with 2 x 4 cm patch of filter paper was saturated with the test item.
-Test groups: 20 female guinea pigs
-Control group: 10 female guinea pigs
-Site: scapular area (6 x 8 cm) in clipped and shaved region (over the injection site)
-Protection site: the patch was covered with aluminium foil and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape.
-Frequency of applications: one application
-Duration: for 48 hours
-Concentrations:
test group:0.5 ml of a 25% (w/w) test substance concentration
control group: vaselinum album only
-Evaluation: the reactiont sites were assesed for erythema and oedema 24 and 48 hours after removal of the dressing.
B. CHALLENGE EXPOSURE (performed on day 22)
-No. of exposures: 2 patches ( 2 x 2 cm) of filter paper were saturated with the highest non-irritating concentration (left flank) and the vehicle only (vaselinum album, applied to the right flank) using the same method as for the epidermal application.
-Exposure period: 24 hours
-Test groups: 20 female guinea pigs
-Control group: 10 female gunea pigs
-Site: flanks ( 5 x 5 cm) area in clipped and shaved region
-Concentrations:
test group
3 %
control group
vehicle only (vaselinum album)
-Evaluation: 24 and 48 hours after removal of the dressings. - Challenge controls:
- yes
- Positive control substance(s):
- yes
- Remarks:
- 4-aminobenzoic acid ethyl ester and 2-mercaptobenzothiazol (tested in two current reference studies)
Results and discussion
- Positive control results:
- 2-mercaptobenzothiazol
No toxic symptoms were evident in the guinea pigs of the control or test group. The 60% of the animals were positive after treatment with a non-irritant test substance concentration of 25% in mineral oil.
4-aminobenzoic acid ethyl ester
No toxic symptoms were evident in the guinea pigs of the control or test group. No deaths occurred. In this study 60% of the animals were positive after treatment with a non-irritant test substance concentration of 25% in mineral oil.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- vaselinum album only (right flank) and 3 % in vaselinum album (left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- vaselinum album only (right flank) and 3 % in vaselinum album (left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- vaselinum album only (right flank) and 3 % in vaselinum album (left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- vaselinum album only (right flank) and 3 % in vaselinum album (left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25 % of 2 -mercaptobenzothiazol in mineral oil
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25 % of 2 -mercaptobenzothiazol in mineral oil
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25 % of 4-aminobenzoic acid ethyl ester in mineral oil
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25 % of 4-aminobenzoic acid ethyl ester in mineral oil
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
SKIN EFFECTS AFTER INTRADERMAL INDUCTION (performed on test day 1)
CONTROL GROUP
-Injection site 1 (1:1 (v/v) mixture of Freund’s Complete Adjuvant [FCA] and physiological saline): the area around the injection site was oedematous and erythematous from test day 2 to 5, and became necrotic from test day 6 to 7. Encrustation was observed from test day 8 to 15 and exfoliation of encrustation from test day 16 to the termination of test.
-Injection site 2 (bi-distilled water): no local symptoms were observed.
-Injection site 3 (1:1 (w/w) mixture of bi-distilled water in a 1:1 (v/v) mixture of FCA and physiological saline): the reactions observed were identical to those obtained at injection site 1 with the mixture of FCA and physiological saline.
As the animals were bandaged with the semi-occlusive dressing no observations of the skin were possible on test day 9.
TEST GROUP
-Injection site 1 (1:1 (v/v) mixture of Freund's Complete Adjuvant [FCA] and physiological saline) : the reactions observed were identical to those obtained in the control group with the mixture of FCA and physiological saline, at injection site 1.
-Injection site 2 (5 % dilution of test article in bi-distilled water) : the area around the injection site was oedematous and green discoloured from test day 2 to 5 and 2 to 10 respectively, necrotic from test day 6 to 7. Encrustation was observed from test day 8 to 15 and exfoliation of encrustation from test day 16 to the termination of test.
-Injection site 3 (5% dilution of test article in a 1:1 (v/v) mixture of FCA and physiological saline): the area around the injection site was oedematous and green discoloured from test day 2 to 5 and 2 to 13 respectively, necrotic from test day 6 to 7. Encrustation was observed from test day 8 to 15 and exfoliation of encrustation from test day 16 to the termination of test.
As the animals were bandaged with the semi-occlusive dressing no observations of the skin were possible on test day 9.
SKIN EFFECTS AFTER EPIDERMAL INDUCTION (performed on test day 8)
CONTROL GROUP
No erythematous or oedematous reaction was observed in the animals treated with vaselinum album only.
TEST GROUP
As the test article stained the skin dark green, it was not possible to determine whether erythema was present. However, no oedema was observed. Green discolouration was noted from test day 11 to 27 (termination of test).
SKIN EFFECTS AFTER THE CHALLENGE (performed on test day 22)
CONTROL and TEST GROUP
No positive reactions were observed in the animals either when treated with vaselinum album alone or when treated with the test article at 3% in vaselinum album. Green discolouration was noted from test day 23 (after removal of the dressing) to 24 (prior to the depilation).
VIABILITY / MORTALITY / MACROSCOPIC FINDINGS
As there were no deaths during the course of the treatment period no necropsies were performed.
CLINICAL SIGNS, SYSTEMIC
No symptoms of systemic toxicity were observed in the animals
BODY WEIGHTS
One animal of the control group, one of the test group, one of the intradermal pretest, three animals of the epidermal pretest I and all animals of the epidermal pretest II lost weight during the acclimatization period. The loss of weight is considered to be of incidental nature.
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified according to the CLP Regulation (EC 1272/2008)
- Conclusions:
- The substancewas found not be sensitiser under the test conditions.
- Executive summary:
In order to assess the cutaneous allergenic potential of test substance, the Maximization-Test was performed in 30 (10 control and 20 test) female albino guinea pigs, in accordance with OECD Guideline No. 406 (1992) and the method B.6 of EEC-Directive 96/54 EEC. Three pre-tests were performed in order to identify the maximally tolerated concentration of the test substance suitable for the induction phase and the suitable non-irritant concentration of the test substance for the challenge application in the main study. For intradermal and epidermal induction, the test item concentrations selected were 5 % in water and 25 % in vaselium album respectively. The highest non-irritating test item concentration used for challenge application was 3% in vaselinum album.
No toxic symptoms were evident in the guinea pigs of the control or test group and no deaths occurred. None of the animals of the test and control groups were observed with positive skin reactions after treatment with the selected non-irritant test substance concentration of the challenge, at both readings (24 and 48 hours).
The test substance is considered to be a non-sensitizer under the test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.